Statement Of Income And Retained Earnings

Modalis Therapeutics Corporation - Filing #7571290

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-2,144,557,000 JPY
-2,063,194,000 JPY
-1,291,208,000 JPY
-1,239,444,000 JPY
Non-operating income
Non-operating income
58,896,000 JPY
76,994,000 JPY
15,136,000 JPY
12,856,000 JPY
Non-operating expenses
Non-operating expenses
4,214,000 JPY
9,590,000 JPY
1,523,000 JPY
4,711,000 JPY
Ordinary profit (loss)
-2,089,875,000 JPY
-1,995,790,000 JPY
-1,277,595,000 JPY
-1,231,299,000 JPY
Extraordinary income
Extraordinary income
285,559,000 JPY
285,559,000 JPY
485,881,000 JPY
485,881,000 JPY
Extraordinary losses
Extraordinary losses
781,126,000 JPY
996,800,000 JPY
JPY
JPY
Profit (loss) before income taxes
-2,585,442,000 JPY
-2,707,031,000 JPY
-791,714,000 JPY
-745,417,000 JPY
Income taxes - current
1,451,000 JPY
1,451,000 JPY
1,333,000 JPY
1,333,000 JPY
Income taxes - deferred
-5,772,000 JPY
-7,794,000 JPY
Profit (loss)
-2,586,894,000 JPY
-2,586,894,000 JPY
-2,586,894,000 JPY
-2,702,709,000 JPY
-2,586,894,000 JPY
-793,047,000 JPY
-793,047,000 JPY
-793,047,000 JPY
-793,047,000 JPY
-738,956,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.